Warning message

  • DIAL was requested successfully but there were no results for this search.
  • DIAL was requested successfully but there were no results for this search.


Bruxelles Woluwe

Selected publications

- Véronique Préat -

  1. Zhao M., Bozzato E., Joudiou N., Ghiassinejad S., Danhier F., Gallez B., Préat V.
    Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.
    J Control Release (2019) 309: 72-81.
  2. Bastiancich C., Bianco J., Vanvarenberg K., Ucakar B., Joudiou N., Gallez B., Bastiat G., Lagarce F., Préat V., Danhier F.
    Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection.
    J Control Release (2017) 264: 45-54
  3. Schleich N., Po C., Jacobs D., Ucakar B., Gallez B., Danhier F., Préat V.
    Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy.
    J Control Release (2014) 194: 82-91.
  4. Danhier F., Ansorena E., Silva J.M., Coco R., Le Breton A., Préat V.
    PLGA-based nanoparticles: an overview of biomedical applications. J Control Release (2012) 161: 505-522.
  5. Danhier F., Feron O., Préat V.
    To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
    J Control Release (2010) 148: 135-146.

- Rita Vanbever-

  1. Guichard M-J, Wilms T., Mahri S., Patil H. P., Hoton D., Ucakar B., Vanvarenberg K., Cheou P., Beka M., Marbaix E., Leal T., Vanbever R.
    PEGylation of recombinant human deoxyribonuclease I provides a long-acting version of the mucolytic for patients with cystic fribrosis.
    Adv Ther (2021) 2000146 (1-17)
  2. Mahri S., Rondon A., Wilms T., Bosquillon C., Vanbever R.
    Biodistribution and elimination pathways of PEGylated recombinant human deoxyribonuclease I after pulmonary delivery in mice.
    J Control Release (2021), 329: 1054-1065
  3. Vanbever R., Loira-Pastoriza C., Dauguet N., Hérin C., Ibouraadaten S., Vanvarenberg K., Ucakar B., Tyteca D., Huaux F.
    Cationic nanoliposomes are efficiently taken up by alveolar macrophages but have little access to dendritic cells and interstitial macrophages in the normal and CpG-stimulated lungs.
    Mol Pharm. (2019) 16: 2048-2059.
  4. Patil H.P., Freches D., Karmani L., Duncan G., Ucakar B., Suk J.S., Hanes J., Gallez B., Vanbever R.
    Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation
    J Control Release (2018) 272: 62-71.
  5. Loira-Pastoriza C., Todoroff J., Vanbever R.
    Delivery strategies for sustained drug release in the lungs (invited review).
    Adv Drug Deliv Rev. (2014) 75: 81-91.

- Gaëtane Leloup - Julian Leprince -

  1. Leprince J.G., Van Nieuwenhuysen J.-P.
    The missed root canal story: aren’t we missing the point?
    Int Endod J. 2020 53, 1162–1166.
  2. Leroy R., Bourgeois J., Verleye L., Declerck D., Depuydt P., Eloot A., Carvalho J.C., Teughels W., Cauwels R., Leprince J., Toma S., Michiels K., Aryanpour S., Vanden Abbeele A., De Bruyne M.
    Guideline on the prudent prescription of antibiotics in the dental office –Supplement. Good Clinical Practice (GCP) Brussels: Belgian Health CareKnowledge Centre (KCE).
    2020. KCE Reports 332S. D/2020/10.273/24.
  3. Hardy C.M.F., Bebelman S., Leloup G., Hadis M.A., Palin W.M., Leprince J.G.
    Investigating the limits of resin-based luting composite photopolymerization through various thicknesses of indirect restorative materials.
    Dent Mater. 2018 May 29. pii: S0109-5641(17)31368-4. doi: 10.1016/j.dental.2018.05.009.
  4. Randolph L.D., Palin W.M., Bebelman S., Devaux J., Gallez B., Leloup G., Leprince J.G.
    Photopolymerization of highly filled dimethacrylate-basedcompositesusing Type I or Type II photoinitiators and varyingco-monomer ratios.
    Dent Mater. (2016) 32:136-48.
  5. Randolph L.D., Palin W.M., Leloup G., Leprince J.G.
    Filler characteristics of modern dental resin composites and their influence on physico-mechanical properties.
    Dent Mater. (2016)32:1586-1599.
  6. Leprince J.G.,Palin W.M., Hadis M.A., Devaux J., Leloup G.
    Progress in dimethacrylate-based dental composite technology and curing efficiency.
    Dent Mater. (2013) 29: 139-156.

- Anne des Rieux -

  1. Carradori D., Labrak Y., Miron V.E., Saulnier P., Eyer J., Préat V., des Rieux A.
    Retinoic acid-loaded NFL-lipid nanocapsules promote oligodendrogenesis in focal white matter lesion.
    Biomaterials (2020), 119653.
  2. Beloqui A., Brayden D.J., Artursson P., Préat V., des Rieux A.
    A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation.
    Nat Protoc. (2017) 12:1387-1399.
  3. Carradori D., Eyer J., Saulnier P., Préat V., des Rieux A.
    The therapeutic contribution of nanomedicine to treat neurodegenerative diseases via neural stem cell differentiation.
    Biomaterials (2017) 123:77-91.
  4. Viswanath A., Vanacker J., Germain L., Leprince J.G., Diogenes A., Shakesheff K.M., White L.J., des Rieux A.
    Extracellular matrix-derived hydrogels for dental stem cell delivery.
    J Biomed Mater Res. A (2017) 105:319-328.
  5. De Berdt P., Vanacker J., Ucakar B., Elens L., Diogenes A., Leprince J.G., Deumens R., des Rieux A.
    Dental Apical Papilla as Therapy for Spinal Cord Injury.
    J Dent Res. (2015) 94:1575-1581.

- Ana Beloqui -

  1. Xu Y., van Hul M., Suriano F., Préat V., Cani PD., Beloqui A.
    Novel strategy for oral peptide delivery in incretin-based diabetes treatment.
    Gut (2020) 69: 911-919.
  2. Xu Y., De Keersmaecker H., Braeckmans K., De Smedt S., Cani P.D., Préat V, Beloqui A.
    Targeted nanoparticles towards increased L cell stimulation as a strategy toimprove oral peptidedelivery in incretin-based diabetes treatment.
    Biomaterials (2020) 120209.
  3. Shrestha N., Bouttefeux O., Vanvarenberg K., Lunquist P., Cunarro J., Tovar S., Khodus G., Andersson E., Keita Å.V., González Dieguez C., Artursson P., Préat V., Beloqui A.
    The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers.
    Nanoscale (2018) 10:603-613
  4. Beloqui A., des Rieux A., Préat V.
    Mechanisms of transport of polymeric and lepidic nanoparticles across the intestinal barrier.
    Adv Drug Deliv Rev. (2016) 106:242-255.
  5. Beloqui A., Solinís M.A., Gascón A.R., del Pozo-Rodríguez A., des Rieux A., Préat V.
    Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier,
    J Control Release (2013) 166:115-123.